Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexey Yuryevich Vorob’Ev has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synthesis of 2-Ferrocenyl[1,2,4]triazolo[1,5-a]azines Derivatives via the Reaction of N-Aminoguanine Salts with Ferrocenecarbonitrile

    by Daniil A. Rykunov, Alina A. Sonina, Alexey Y. Vorob’Ev

    The corresponding derivatives of 2-ferrocenyl[1,2,4]triazolo[1,5-a]azines were obtained in moderate yields through the reaction of ferrocenecarbonitrile with salts of N-aminopyridine, 8-hydroxyquinoline, and 1,10-phenanthroline in an alkaline aqueous-methanolic medium.

  • Open Access

    Luminescence Enhancement of an Indium(III) Complex Through Introducing an Electron-Donating Group in (1H-Pyrazol-1-yl)pyridazine

    by Evgeniia Sergeevna Sedykh, Nikita Vasilievich Naletov, Veronika Igorevna Komlyagina, Yulia Sergeevna Spiridonova, Elvira Ilgizovna Musina, Marianna Ivanovna Rakhmanova, Nikolay Filippovich Romashev, Katerina Aleksandrovna Vinogradova, Marat Damirovich Nafikov, Alexey Yuryevich Vorob’Ev, et al.

    New deep-blue-emitting materials are crucial for Organic Light-Emitting Diode (OLED) technology, as iridium-based blue emitters often suffer from degradation and inadequate colour purity. Indium(III) complexes offer an alternative, since the d10 configuration of In3+ precludes metal-centred transitions, and emission arises from ligand-centred states via the chelation-enhanced fluorescence (CHEF) effect. We previously reported complexes 1 ([In(LH)(H2O)Cl3]) and 2 ([In(LMe)2Cl2][InCl4]), which exhibited excitation-dependent emission, and the electronic transitions were assigned as ILCT for 1 and mixed ILCT/LL’CT for 2. Herein, we present a new complex, complex 3, i.e., [In(LMorph)2Cl2][InCl4], where LMorph contains electron-donating morpholine substituents, in contrast to the acceptor chloride group in LH and LMe. Complex 3 was characterised by elemental CHN analysis, infrared spectroscopy (IR), nuclear magnetic resonance spectroscopy (NMR), ultraviolet–visible spectroscopy (UV-Vis), single-crystal X-ray diffraction analysis (SC-XRD), and photoluminescence. The ionic structure of 3 is analogous to 2, with a cis-octahedral [In(LMorph)2Cl2]+ cation and tetrahedral [InCl4]− anion. The UV-Vis spectrum of 3 shows a significant bathochromic shift relative to 1 and 2 which is attributable to the morpholine group. TD-DFT calculations were employed to assign the electronic transitions. The introduction of a morpholino group into the pyridazine ring resulted in significant changes to the solid-state photoluminescence properties of the indium complex: (i) the emission maximum shifted to the red region (CIE 1931 coordinates: 0.1725, 0.2487), (ii) the lifetime increased by an order of magnitude, and (iii) the quantum yield rose to 15%. This work highlights that substituent variation on the pyrazolyl–pyridazine scaffold provides a versatile route to tune the structural and photophysical properties of indium(III) complexes.

  • Synthesis and physico-chemical study of new fluorescent N -naphthimidazole phosphoramidate oligonucleotides

    by Alina I. Novgorodtseva, Aleksey Y. Vorob’EV, Igor R. Filippov, Victor M. Golyshev, Anton A. Berdugin, Ivan I. Yushin, Svetlana V. Vasilyeva, Alexander A. Lomzov, Igor Philippov

    This work describes a new class of backbone-modified oligonucleotides bearing an internucleotide P N -naphthimidazole phosphoramidate group, termed phosphoramidate polyaromatic azole oligonucleotides (PPAAOs).

  • Open Access

    (R)-10-((((2-(3,4-Dihydroxyphenyl)-2-hydroxyethyl)(methyl)carbamoyl)oxy)methyl)-1,3,5,5,7,9-hexamethyl-5H-dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinin-4-ium-5-uide

    by Mikhail A. Panfilov, Alexey Yu. Vorob’Ev, Alexander E. Moskalensky

    The BODIPY core has emerged as a versatile scaffold for the design of photoremovable protecting groups (PPGs). Herein, we report the synthesis of a novel BODIPY–epinephrine conjugate linked via a carbamate moiety, enabling light-triggered release of the active compound (epinephrine, also known as adrenaline). The structure of the obtained product was confirmed by 1H and M 13C NMR spectroscopy as well as high-resolution mass spectrometry (HRMS). The described conjugate represents a potential tool for the photoactivated modulation of biologically relevant processes.

  • Open Access

    Modulating Photodissociation and Photobleaching via Plasmon Resonance to Enhance Light-Induced Nitric Oxide Release

    by Danil V. Shershnev, Natalia A. Virts, Igor A. Gladskikh, Pavel V. Geydt, Mikhail A. Panfilov, Alexey Yu. Vorob’ev, Alexander E. Moskalensky

    Localized therapeutic action and targeted drug release offer compelling advantages over traditional systemic drug administration. This is particularly important for nitric oxide (NO), whose biological effects vary greatly depending on concentration and cellular environment. Light-sensitive NO donors are promising for achieving precise, on-demand NO release. However, their efficiency and photostability are limited by competing photophysical processes and the generation of reactive oxygen species (ROS). In this study, we investigate hybrid systems composed of photosensitive nitric oxide (NO) donors and silver island films (SIFs). The influence of localized surface plasmon on non-radiative relaxation pathways and ROS generation is the main focus of the paper. Upon excitation at 500 nm, we observed several-fold increase in NO release, attributed to resonant interactions between the plasmonic field and the dye molecules. By tuning the thickness of a SiO2 buffer layer, we identified key parameters affecting process efficiency: the spectral overlap between the plasmon resonance and the sensitizer’s absorption band, and the distance between the nanoparticle and the molecule. Additionally, singlet oxygen generation increase was observed. These findings demonstrate the potential of plasmonic enhancement to controllably boost photochemical activity in organic systems, paving the way for advanced applications in phototherapy and biomedical diagnostics.

  • Open Access

    (Z)-1-(3,5-Dichloro-2H-pyrrol-2-ylidene)-N,N-dimethylmethanamine

    by Daniil Rykunov, Alina Sonina, Aleksey Vorob’ev

    The Vilsmeier–Haack reaction is a convenient method for the formylation of electron-rich aromatic compounds. However, this interaction sometimes gives specific side products. We report the isolation and structural characterization of a novel compound (Z)-1-(3,5-dichloro-2-pyrrolylidene)-N,N-dimethylmethanamine obtained as a side product during the formylation of 2-chloropyrrole. The product was characterized using NMR spectroscopy and X-ray crystallography.

  • Open Access

    Reducing the Formation of Toxic Byproducts During the Photochemical Release of Epinephrine

    by Mikhail A. Panfilov, Ezhena S. Starodubtseva, Tatyana Yu. Karogodina, Alexey Yu. Vorob’ev, Alexander E. Moskalensky

    Engineered light-sensitive molecules offer a sophisticated toolkit for the manipulation of biological systems with both spatial and temporal precision. Notably, artificial “caged” compounds can activate specific receptors solely in response to light exposure. However, the uncaging process can lead to the formation of potentially harmful byproducts. For example, the photochemical release of adrenaline (epinephrine) is accompanied by the formation of adrenochrome, which has neuro- and cardiotoxic effects. To investigate this effect in detail, we synthesized and compared two “caged” epinephrine analogs. The first was a classical compound featuring an ortho-nitrobenzyl protecting group attached to the amino group of epinephrine. The second analog retained the ortho-nitrobenzyl group but included an additional carbamate linker. The photolysis of both compounds was conducted under identical conditions, and the resulting products were analyzed using UV–Vis spectroscopy, chromatography, and NMR techniques. Surprisingly, while the classical compound led to the formation of adrenochrome, the carbamate-type caged epinephrine did not produce this byproduct, resulting in the clean release of the active substance. Subsequently, we assessed the novel compound in an in vitro platelet activation assay. The results demonstrated that the uncaging of epinephrine significantly enhances platelet activation, making it a valuable tool for advanced signaling studies.


  • Open Access

    (Z)-1-(3,5-dichloro-2H-pyrrol-2-ylidene)-N,N-dimethylmethanamine

    by Daniil Rykunov, Alina Sonina, Aleksey Vorob’ev

    The Vilsmeier-Haack reaction is a convenient method for the formylation of electron-rich aromatic compounds. However, this interaction sometimes gives specific side products. We report the isolation and structural characterization of a novel compond (Z)-1-(3,5-dichloro-2-pyrrolidin)-N,N-dimethylmethanamine obtained as a side product during the formylation of 2-chloropyrrole. The product was characterized using NMR spectroscopy and X-ray crystallography.

  • Open Access

    Nitric Oxide Photorelease from Silicone Films Doped with N-Nitroso BODIPY

    by Natalia A. Virts, Tatyana Yu. Karogodina, Mikhail A. Panfilov, Alexey Yu. Vorob’ev, Alexander E. Moskalensky

    Nitric oxide (NO) is a unique biochemical mediator involved in the regulation of vital processes. Light-controllable NO releasers show promise in the development of smart therapies. Here, we present a novel biocompatible material based on polydimethylsiloxane (PDMS) doped with BODIPY derivatives containing an N-nitroso moiety that is capable of the photoinduced generation of NO. We study the green-light-induced NO-release properties with the following three methods: electrochemical gas-phase sensor, liquid-phase sensor, and the Griess assay. Prolonged release of NO from the polymer films after short irradiation by narrow-band LED light sources and a laser beam is demonstrated. Importantly, this was accompanied by no or little release of the parent compound (BODIPY-based photodonor). Silicone films with the capability of controllable and clean NO release can potentially be used as a highly portable NO delivery system for different therapeutic applications.